Impulse Dynamics: Funding, Investors & Team (Sep 2026)
Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediate and powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance. Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information.
Impulse Dynamics has raised $455M across 4 funding rounds on record, the most recent an undisclosed round of $158M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Impulse Dynamics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Impulse Dynamics Funding Rounds
Impulse Dynamics raised $60.0M in a Series D announced in Jan 2021.
1.3 years later, an undisclosed round of $101M was announced in May 2022.
1.8 years later, an undisclosed round of $136M was announced in Feb 2024.
1.8 years later, an undisclosed round of $158M was announced in Dec 2025.
Impulse Dynamics Founders and Leadership Team
Contact details for the Impulse Dynamics team: 1 of 2 have an email address on file.
Start 14-day free trial →Impulse Dynamics Funding Compared to Other Biotechnology Startups
Impulse Dynamics' latest round of $158M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Impulse Dynamics in Biotechnology and Stuttgart
Companies Similar to Impulse Dynamics
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Impulse Dynamics Funding FAQs
What does Impulse Dynamics do?
Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediate and powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance. Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information.
How much funding has Impulse Dynamics raised?
Impulse Dynamics has raised $455M across 4 rounds on record. The most recent is an undisclosed round of $158M announced in Dec 2025.
When did Impulse Dynamics last raise funding?
Impulse Dynamics' most recent funding round on record is an undisclosed round of $158M, announced in Dec 2025.
Who founded Impulse Dynamics?
FundedIQ lists Lewis Pell (Founder) at Impulse Dynamics.
Who is the CEO of Impulse Dynamics?
Simos Kedikoglou is listed as CEO at Impulse Dynamics.
Where is Impulse Dynamics headquartered?
Impulse Dynamics is based in Stuttgart, Baden-Wurttemberg, Germany.
How many employees does Impulse Dynamics have?
Impulse Dynamics is in the 101-250 employee band.
How does Impulse Dynamics' funding compare to other Biotechnology startups?
Impulse Dynamics' latest round of $158M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Impulse Dynamics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Impulse Dynamics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.